Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
national blog main
7
×
biotech
clinical trials
life sciences
amgen
eli lilly
fda
national top stories
new york blog main
texas blog main
texas top stories
boston blog main
boston top stories
calcitonin gene-related peptide
indiana blog main
indiana top stories
migraine
national
teva pharmaceutical
accelerator
allergan
biohaven
boulder/denver blog main
boulder/denver top stories
chronic migraine
detroit blog main
detroit top stories
drugs
episodic migraine
eptinezumab
erenumab
fremanezumab
galcanezumab
houston
innovation
medical devices
migraine research foundation
new york top stories
people
raleigh-durham blog main
What
class
7
×
new
fda
medicines
migraine
approval
drug
won
accelerator
announced
approved
developed
health
latest
nod
pain
starts
startups
adults
allergan
amgen
arguments
based
begin
big
biosciences
bio’s
brings
bubbles
buys
candidates
catch
cells
center’s
chosen
clinical
codiak
cohort
commercialized
companies
Language
unset
Current search:
class
×
photo
×
" national blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
TMCx, Microsoft Buys XOXCO, Self Lender Raises $10M & More TX Tech
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Health Wildcatters Splits Program in Two, Debuts Latest Startup Class
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines